Human Pathology: highly developed IHC antibodies for tumor diagnostics

Dianova’s development programme aimed at providing better antibodies for tumor diagnostics redefines antibody performance in immunohistochemistry (IHC). All antibodies are specifically developed, screened and validated for the special requirements of immunohistochemical staining of formalin-fixed paraffin-embedded human tissues (FFPE), especially for use on automated stainers. Only antibodies with extraordinary specificity and sensitivity pass the scope of performance testing which exceeds industrial standards by testing on more than 250 tissues, on transfected cell lines, in ELISA, and WB. The growing product range includes a complete pathology portfolio of clinically relevant known markers and unique markers for new trends in diagnostic immunohistochemistry of tumors are in the pipeline.